179 related articles for article (PubMed ID: 24200267)
1. Predictive value of interferon-gamma release assays for postpartum active tuberculosis in HIV-1-infected women.
Jonnalagadda SR; Brown E; Lohman-Payne B; Wamalwa D; Farquhar C; John-Stewart GC
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1552-7. PubMed ID: 24200267
[TBL] [Abstract][Full Text] [Related]
2. Consistency of Mycobacterium tuberculosis-specific interferon-gamma responses in HIV-1-infected women during pregnancy and postpartum.
Jonnalagadda SR; Brown E; Lohman-Payne B; Wamalwa D; Farquhar C; Tapia K; Cranmer LM; John-Stewart GC
Infect Dis Obstet Gynecol; 2012; 2012():950650. PubMed ID: 22496602
[TBL] [Abstract][Full Text] [Related]
3. Latent tuberculosis detection by interferon γ release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children.
Jonnalagadda S; Lohman Payne B; Brown E; Wamalwa D; Maleche Obimbo E; Majiwa M; Farquhar C; Otieno P; Mbori-Ngacha D; John-Stewart G
J Infect Dis; 2010 Dec; 202(12):1826-35. PubMed ID: 21067370
[TBL] [Abstract][Full Text] [Related]
4. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.
Jiang W; Shao L; Zhang Y; Zhang S; Meng C; Xu Y; Huang L; Wang Y; Wang Y; Weng X; Zhang W
BMC Immunol; 2009 May; 10():31. PubMed ID: 19476627
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and chemokine expression profiles in response to Mycobacterium tuberculosis stimulation are altered in HIV-infected compared to HIV-uninfected subjects with active tuberculosis.
Waruk JL; Machuki Z; Mesa C; Juno JA; Anzala O; Sharma M; Ball TB; Oyugi J; Kiazyk S
Tuberculosis (Edinb); 2015 Sep; 95(5):555-61. PubMed ID: 26073895
[TBL] [Abstract][Full Text] [Related]
6. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
7. Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway.
Pullar ND; Steinum H; Tonby K; Heggelund L; Leiva RA; Ofstad R; Bruun JN; Dyrhol-Riise AM
Int J Tuberc Lung Dis; 2014 Feb; 18(2):180-7. PubMed ID: 24429310
[TBL] [Abstract][Full Text] [Related]
8. Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot.TB Test.
Sun HY; Hsueh PR; Liu WC; Su YC; Chang SY; Hung CC; Chang SC
PLoS One; 2015; 10(5):e0125260. PubMed ID: 25938227
[TBL] [Abstract][Full Text] [Related]
9. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
[TBL] [Abstract][Full Text] [Related]
10. Incidence and correlates of tuberculosis IGRA conversion among HIV-infected postpartum women.
Jonnalagadda S; LaCourse SM; Otieno P; Lohman-Payne B; Maleche-Obimbo E; Cranmer LM; John-Stewart GC
Int J Tuberc Lung Dis; 2015 Jul; 19(7):792-8. PubMed ID: 26056103
[TBL] [Abstract][Full Text] [Related]
11. Combining interferon-
Lv D; Liu Y; Guo F; Wu A; Mo Y; Wang S; Chu J
J Int Med Res; 2020 Jun; 48(6):300060520925660. PubMed ID: 32527178
[TBL] [Abstract][Full Text] [Related]
12. Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?
Ling DI; Pai M; Davids V; Brunet L; Lenders L; Meldau R; Calligaro G; Allwood B; van Zyl-Smit R; Peter J; Bateman E; Dawson R; Dheda K
Eur Respir J; 2011 Sep; 38(3):649-56. PubMed ID: 21349910
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.
Sultan B; Benn P; Mahungu T; Young M; Mercey D; Morris-Jones S; Miller RF
Int J STD AIDS; 2013 Oct; 24(10):775-9. PubMed ID: 23970606
[TBL] [Abstract][Full Text] [Related]
14. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
[TBL] [Abstract][Full Text] [Related]
15. An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa.
Kroon EE; Kinnear CJ; Orlova M; Fischinger S; Shin S; Boolay S; Walzl G; Jacobs A; Wilkinson RJ; Alter G; Schurr E; Hoal EG; Möller M
EBioMedicine; 2020 Nov; 61():103053. PubMed ID: 33038764
[TBL] [Abstract][Full Text] [Related]
16. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
Desalegn G; Tsegaye A; Gebreegziabiher D; Aseffa A; Howe R
BMC Immunol; 2019 Oct; 20(1):35. PubMed ID: 31601184
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a New IFN-γ Release Assay for Rapid Diagnosis of Active Tuberculosis in a High-Incidence Setting.
Li G; Li F; Zhao HM; Wen HL; Li HC; Li CL; Ji P; Xu P; Wu K; Hu ZD; Lu SH; Lowrie DB; Lv JX; Fan XY
Front Cell Infect Microbiol; 2017; 7():117. PubMed ID: 28443247
[TBL] [Abstract][Full Text] [Related]
18. Improving the predictive value of interferon-gamma release assays: do our methods go far enough?
Kik SV; Rangaka MX
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1516. PubMed ID: 24200260
[No Abstract] [Full Text] [Related]
19. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.
Clark SA; Martin SL; Pozniak A; Steel A; Ward B; Dunning J; Henderson DC; Nelson M; Gazzard B; Kelleher P
Clin Exp Immunol; 2007 Nov; 150(2):238-44. PubMed ID: 17672869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
